The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT05669755




Registration number
NCT05669755
Ethics application status
Date submitted
20/12/2022
Date registered
3/01/2023
Date last updated
22/05/2024

Titles & IDs
Public title
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
Scientific title
The Cardiovascular Safety and Efficacy of Cagrilintide 2.4 mg s.c. in Combination With Semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) Once-weekly in Participants With Established Cardiovascular Disease
Secondary ID [1] 0 0
U1111-1270-0943
Secondary ID [2] 0 0
NN9838-4942
Universal Trial Number (UTN)
Trial acronym
REDEFINE 3
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Cardiovascular Disease 0 0
Condition category
Condition code

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - Cagrilintide
Treatment: Drugs - Semaglutide
Treatment: Drugs - Placebo

Experimental: CagriSema 2.4 mg/2.4 mg - Participants will receive 2.4 milligrams (mg) cagrilintide and 2.4 mg semaglutide subcutaneously (s.c.) once-weekly after a dose escalation period of 16 weeks during the maintenance period of 219 weeks.

Placebo Comparator: Placebo - Participants will receive placebo matched to cagrilintide and placebo matched to semaglutide s.c. once weekly for 235 weeks.


Treatment: Drugs: Cagrilintide
Participants will receive 2.4 mg cagrilintide s.c. once-weekly after a dose escalation period of 16 weeks for 219 weeks.

Treatment: Drugs: Semaglutide
Participants will receive 2.4 mg semaglutide s.c. once-weekly after a dose escalation period of 16 weeks for 219 weeks.

Treatment: Drugs: Placebo
Participants will receive placebo matched to cagrilintide and placebo matched to semaglutide subcutaneously.

Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Time to first occurrence of major adverse cardiovascular event (MACE), a composite endpoint consisting of: cardiovascular (CV) death, non-fatal myocardial infarction, non-fatal stroke - Measured in days.
Timepoint [1] 0 0
From baseline (week 0) to end of study (up to 242 weeks or more)
Secondary outcome [1] 0 0
Time to occurrence of CV death - Measured in days.
Timepoint [1] 0 0
From baseline (week 0) to end of study (up to 242 weeks or more)
Secondary outcome [2] 0 0
Time to first occurrence of a composite heart failure endpoint consisting of: CV death, heart failure, hospitalisation and urgent heart failure visit - Measured in days.
Timepoint [2] 0 0
From baseline (week 0) to end of study (up to 242 weeks or more)
Secondary outcome [3] 0 0
Time to first occurrence of a composite endpoint: Onset of persistent =40% reduction in eGFRcr (CKD-EPI), Onset of persistent eGFRcr (CKD-EPI) <15 mL/min/1.73 m2, Initiation of chronic kidney replacement therapy, Kidney death and CV death - CKD-EPI is Chronic Kidney Disease Epidemiology Collaboration. Measured in days.
Timepoint [3] 0 0
From baseline (week -3) to end of study (up to 242 weeks or more)
Secondary outcome [4] 0 0
Time to first occurrence of all-cause death - Measured in days.
Timepoint [4] 0 0
From baseline (week 0) to end of study (up to 242 weeks or more)
Secondary outcome [5] 0 0
Time to first occurrence of an expanded MACE composite endpoint consisting of: CV death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularisation and unstable angina requiring hospitalisation - Measured in days.
Timepoint [5] 0 0
From baseline (week 0) to end of study (up to 242 weeks or more)
Secondary outcome [6] 0 0
Time to first occurrence of a composite endpoint consisting of: all-cause death, non-fatal myocardial infarction and non-fatal stroke - Measured in days.
Timepoint [6] 0 0
From baseline (week 0) to end of study (up to 242 weeks or more)
Secondary outcome [7] 0 0
Time to first occurrence of myocardial infarction (fatal and non-fatal) - Measured in days.
Timepoint [7] 0 0
From baseline (week 0) to end of study (up to 242 weeks or more)
Secondary outcome [8] 0 0
Time to first occurrence of stroke (fatal and non-fatal) - Measured in days.
Timepoint [8] 0 0
From baseline (week 0) to end of study (up to 242 weeks or more)
Secondary outcome [9] 0 0
Relative change in body weight - Measured in percentage (%).
Timepoint [9] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [10] 0 0
Change in waist circumference - Measured in centimeters (cm).
Timepoint [10] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [11] 0 0
Change in systolic blood pressure (SBP) - Measured in millimeters of mercury (mmHg).
Timepoint [11] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [12] 0 0
Change in diastolic blood pressure (DBP) - Measured in mmHg.
Timepoint [12] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [13] 0 0
Relative change in lipids: Total cholesterol, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, very-low-density lipoprotein (VLDL) cholesterol, triglycerides and free fatty acids - Measured in percentage.
Timepoint [13] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [14] 0 0
Change in glycated haemoglobin (HbA1c) - Measured in percentage-points.
Timepoint [14] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [15] 0 0
Change in Short Form 36 v2.0 acute (SF-36v2) - SF-36v2.0 is a 36-item commonly used generic clinical outcome assessment (COA) instrument measuring health-related quality of life and general health status across disease areas. The SF-36v2.0 for adults with a 1 week recall period (i.e. acute version) measures the individual overall health-related quality of life in 8 health domains (physical functioning, role-physical, bodily pain, general health, social functioning, role emotional, vitality and mental health). Furthermore, it includes two aggregated scores: a physical component summary score and a mental component summary score. Range of score for domains and component summary scores : 1-100 (Higher scores indicated a better health state).
Timepoint [15] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [16] 0 0
Number of treatment emergent serious adverse events (TESAEs) - Measured in count of events.
Timepoint [16] 0 0
From baseline (week 0) to end of study (up to 242 weeks or more)
Secondary outcome [17] 0 0
Number of event adjudication committee (EAC)-confirmed malignant neoplasms - Measured as count of events.
Timepoint [17] 0 0
From baseline (week 0) to end of study (up to 242 weeks or more)
Secondary outcome [18] 0 0
Number of severe hypoglycaemic episodes (level 3) (only for participants with type 2 diabetes mellitus [T2D] at screening) - Measured as count of events.
Timepoint [18] 0 0
From baseline (week 0) to end of study (up to 242 weeks or more)
Secondary outcome [19] 0 0
Change from baseline in high-sensitivity C-reactive protein (hsCRP) - Measured in milligram per liter (mg/L)
Timepoint [19] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [20] 0 0
Change from baseline in tumour necrosis factor alpha (TNF-a) - Measured in picograms per milliliter (pg/mL)
Timepoint [20] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [21] 0 0
Change from baseline in Interleukin 6 (IL-6) - Measured in pg/mL.
Timepoint [21] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [22] 0 0
Change from baseline in Interleukin 1 beta (IL-1ß) - Measured in pg/mL.
Timepoint [22] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [23] 0 0
Change in pain intensity rated by Numerical Rating Scale (NRS) - The NRS rates average pain intensity in the last 24 hours on a scale from 0 to 10, with 0 meaning 'No pain' and '10' meaning 'Pain as bad as you can imagine'.
Timepoint [23] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [24] 0 0
Change in Pittsburgh Sleep Quality Index (PSQI) - The Pittsburgh Sleep Quality Index is a 19-item, self-rated questionnaire, assessed various aspects of sleep, sleep quality, and sleep disturbances. The PSQI is composed of 7 components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The sum of scores for these 7 components yields 1 global score. An overall score ranges from 0 to 21, where lower scores denote a healthier sleep quality.
Timepoint [24] 0 0
From baseline (week 0) to 120 weeks
Secondary outcome [25] 0 0
Change in neuropathy status by baseline neuropathy group (painful neuropathy, painless neuropathy or no neuropathy) - Measured in percentage.
Timepoint [25] 0 0
From baseline (week 0) to 120 weeks

Eligibility
Key inclusion criteria
- Male or female

- Age above or equal to 55 years at the time of signing informed consent

- Body mass index (BMI) greater than or equal to (>=) 25.0 kilograms per meter square
(kg/m^2)

- Established CVD as evidenced by at least one of the following:

1. Prior myocardial infarction

2. Prior stroke (ischemic or haemorrhagic stroke)

3. Symptomatic peripheral arterial disease (PAD) defined as at least one of the
following:

1. Intermittent claudication with an ankle-brachial index (ABI) less than (<)
0.85 at rest

2. Intermittent claudication with a >= 50% stenosis in a lower extremity
peripheral artery documented by X-ray angiography, magnetic resonance (MR)
angiography, computed tomography (CT) angiography or Doppler ultrasound

3. Prior revascularization procedure of a lower extremity peripheral artery

4. Lower extremity amputation at or above ankle due to atherosclerotic disease
(excluding e.g., trauma or osteomyelitis)

For participants with T2D at screening the following inclusion criteria also apply:

- Diagnosed with type 2 diabetes mellitus (T2D) >= 180 days before screening

- HbA1c 6.5%-10% (48-86 millimoles per mole [mmol/mol]) (both inclusive), as measured by
central laboratory at screening

- Treatment with either:

1. Lifestyle intervention alone

2. 1-3 marketed oral antidiabetic drugs (OADs) (metformin, a-glucosidase inhibitors
(AGI), glinides, sodium-glucose co-transporter 2 inhibitor (SGLT2i), dipeptidyl
peptidase 4 (DPP4)-inhibitors, thiazolidinediones, or sulphonylureas (SU) as a
single agent or in combination) according to local label

3. Basal insulin alone or in combination with up to two marketed OADs, all according
to local label
Minimum age
55 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Myocardial infarction, stroke, hospitalization for unstable angina pectoris or
transient ischaemic attack within 60 days before screening

- Planned coronary, carotid or peripheral artery revascularisation known on the day of
screening

- Heart failure classified as being in New York Heart Association (NYHA) Class IV at
screening

- Treatment with any glucagon-like peptide-1 (GLP-1) receptor agonist (RA) or a
medication with GLP-1 activity within 90 days before screening

- End stage renal disease defined as estimated glomerular filtration rate (eGFR) < 15
millileters per minutes per 1.73^2 (mL/min/1.73 m^2), as measured by the central
laboratory at screening

- Chronic or intermittent haemodialysis or peritoneal dialysis

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,TAS,VIC,WA
Recruitment hospital [1] 0 0
Gosford Renal Research - Gosford
Recruitment hospital [2] 0 0
Paratus Clinical - Kanwal
Recruitment hospital [3] 0 0
Southern Neurology - Kogarah
Recruitment hospital [4] 0 0
Liverpool Hospital - Liverpool
Recruitment hospital [5] 0 0
Macquarie University - Macquarie Park
Recruitment hospital [6] 0 0
GenesisCare - Auchenflower
Recruitment hospital [7] 0 0
Logan Hospital - Meadowbrook
Recruitment hospital [8] 0 0
Nightingale Research - Adelaide
Recruitment hospital [9] 0 0
Royal Adelaide Hospital Cardiovascular Clinical Trials - Adelaide
Recruitment hospital [10] 0 0
HeartCare SA - Leabrook
Recruitment hospital [11] 0 0
Royal Hobart Hospital - Hobart
Recruitment hospital [12] 0 0
Baker IDI Heart and Diabetes Institute - Melbourne
Recruitment hospital [13] 0 0
HeartCare WA (Joondalup) - Joondalup
Recruitment hospital [14] 0 0
One Clinical Research - Nedlands
Recruitment hospital [15] 0 0
Clinitrials - Perth
Recruitment postcode(s) [1] 0 0
2250 - Gosford
Recruitment postcode(s) [2] 0 0
2259 - Kanwal
Recruitment postcode(s) [3] 0 0
2217 - Kogarah
Recruitment postcode(s) [4] 0 0
2170 - Liverpool
Recruitment postcode(s) [5] 0 0
2109 - Macquarie Park
Recruitment postcode(s) [6] 0 0
4066 - Auchenflower
Recruitment postcode(s) [7] 0 0
4131 - Meadowbrook
Recruitment postcode(s) [8] 0 0
5000 - Adelaide
Recruitment postcode(s) [9] 0 0
5068 - Leabrook
Recruitment postcode(s) [10] 0 0
7000 - Hobart
Recruitment postcode(s) [11] 0 0
3004 - Melbourne
Recruitment postcode(s) [12] 0 0
6027 - Joondalup
Recruitment postcode(s) [13] 0 0
6009 - Nedlands
Recruitment postcode(s) [14] 0 0
6000 - Perth
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
California
Country [4] 0 0
United States of America
State/province [4] 0 0
Connecticut
Country [5] 0 0
United States of America
State/province [5] 0 0
Florida
Country [6] 0 0
United States of America
State/province [6] 0 0
Georgia
Country [7] 0 0
United States of America
State/province [7] 0 0
Idaho
Country [8] 0 0
United States of America
State/province [8] 0 0
Illinois
Country [9] 0 0
United States of America
State/province [9] 0 0
Indiana
Country [10] 0 0
United States of America
State/province [10] 0 0
Iowa
Country [11] 0 0
United States of America
State/province [11] 0 0
Kansas
Country [12] 0 0
United States of America
State/province [12] 0 0
Kentucky
Country [13] 0 0
United States of America
State/province [13] 0 0
Louisiana
Country [14] 0 0
United States of America
State/province [14] 0 0
Maryland
Country [15] 0 0
United States of America
State/province [15] 0 0
Michigan
Country [16] 0 0
United States of America
State/province [16] 0 0
Missouri
Country [17] 0 0
United States of America
State/province [17] 0 0
Nebraska
Country [18] 0 0
United States of America
State/province [18] 0 0
New Hampshire
Country [19] 0 0
United States of America
State/province [19] 0 0
New Mexico
Country [20] 0 0
United States of America
State/province [20] 0 0
New York
Country [21] 0 0
United States of America
State/province [21] 0 0
North Carolina
Country [22] 0 0
United States of America
State/province [22] 0 0
North Dakota
Country [23] 0 0
United States of America
State/province [23] 0 0
Ohio
Country [24] 0 0
United States of America
State/province [24] 0 0
Pennsylvania
Country [25] 0 0
United States of America
State/province [25] 0 0
South Carolina
Country [26] 0 0
United States of America
State/province [26] 0 0
Tennessee
Country [27] 0 0
United States of America
State/province [27] 0 0
Texas
Country [28] 0 0
United States of America
State/province [28] 0 0
Virginia
Country [29] 0 0
United States of America
State/province [29] 0 0
Washington
Country [30] 0 0
United States of America
State/province [30] 0 0
Wisconsin
Country [31] 0 0
Argentina
State/province [31] 0 0
Buenos Aires
Country [32] 0 0
Argentina
State/province [32] 0 0
Santa Fe
Country [33] 0 0
Argentina
State/province [33] 0 0
Caba
Country [34] 0 0
Argentina
State/province [34] 0 0
Capital Federal
Country [35] 0 0
Argentina
State/province [35] 0 0
Córdoba
Country [36] 0 0
Argentina
State/province [36] 0 0
Mar del Plata
Country [37] 0 0
Argentina
State/province [37] 0 0
Morón
Country [38] 0 0
Argentina
State/province [38] 0 0
San Nicolás
Country [39] 0 0
Argentina
State/province [39] 0 0
Santiago del Estero
Country [40] 0 0
Brazil
State/province [40] 0 0
CE
Country [41] 0 0
Brazil
State/province [41] 0 0
Espirito Santo
Country [42] 0 0
Brazil
State/province [42] 0 0
Parana
Country [43] 0 0
Brazil
State/province [43] 0 0
Rio Grande Do Sul
Country [44] 0 0
Brazil
State/province [44] 0 0
RJ
Country [45] 0 0
Brazil
State/province [45] 0 0
Sao Paulo
Country [46] 0 0
Bulgaria
State/province [46] 0 0
Bankya
Country [47] 0 0
Bulgaria
State/province [47] 0 0
Burgas
Country [48] 0 0
Bulgaria
State/province [48] 0 0
Dimitrovgrad
Country [49] 0 0
Bulgaria
State/province [49] 0 0
Haskovo
Country [50] 0 0
Bulgaria
State/province [50] 0 0
Kozloduy
Country [51] 0 0
Bulgaria
State/province [51] 0 0
Panagyurishte
Country [52] 0 0
Bulgaria
State/province [52] 0 0
Pazardzhik
Country [53] 0 0
Bulgaria
State/province [53] 0 0
Pleven
Country [54] 0 0
Bulgaria
State/province [54] 0 0
Plovdiv
Country [55] 0 0
Bulgaria
State/province [55] 0 0
Ruse
Country [56] 0 0
Bulgaria
State/province [56] 0 0
Samokov
Country [57] 0 0
Bulgaria
State/province [57] 0 0
Sliven
Country [58] 0 0
Bulgaria
State/province [58] 0 0
Smolyan
Country [59] 0 0
Bulgaria
State/province [59] 0 0
Sofia
Country [60] 0 0
Bulgaria
State/province [60] 0 0
Stara Zagora
Country [61] 0 0
Bulgaria
State/province [61] 0 0
Varna
Country [62] 0 0
Bulgaria
State/province [62] 0 0
Velingrad
Country [63] 0 0
Bulgaria
State/province [63] 0 0
Yambol
Country [64] 0 0
Canada
State/province [64] 0 0
Alberta
Country [65] 0 0
Canada
State/province [65] 0 0
New Brunswick
Country [66] 0 0
Canada
State/province [66] 0 0
Nova Scotia
Country [67] 0 0
Canada
State/province [67] 0 0
Ontario
Country [68] 0 0
Canada
State/province [68] 0 0
Quebec
Country [69] 0 0
Colombia
State/province [69] 0 0
Barranquilla
Country [70] 0 0
Colombia
State/province [70] 0 0
Santander
Country [71] 0 0
Colombia
State/province [71] 0 0
Bogota
Country [72] 0 0
Colombia
State/province [72] 0 0
Rionegro
Country [73] 0 0
Denmark
State/province [73] 0 0
Region Hovedstaden
Country [74] 0 0
Denmark
State/province [74] 0 0
Region Midtjylland
Country [75] 0 0
Denmark
State/province [75] 0 0
Region Sjælland
Country [76] 0 0
Denmark
State/province [76] 0 0
Region South
Country [77] 0 0
Denmark
State/province [77] 0 0
Aarhus N
Country [78] 0 0
Denmark
State/province [78] 0 0
Herning
Country [79] 0 0
Denmark
State/province [79] 0 0
Hillerød
Country [80] 0 0
Denmark
State/province [80] 0 0
Slagelse
Country [81] 0 0
Denmark
State/province [81] 0 0
Viborg
Country [82] 0 0
France
State/province [82] 0 0
Annonay cedex
Country [83] 0 0
France
State/province [83] 0 0
Annonay
Country [84] 0 0
France
State/province [84] 0 0
Bobigny
Country [85] 0 0
France
State/province [85] 0 0
Grenoble cedex 9
Country [86] 0 0
France
State/province [86] 0 0
Le Coudray
Country [87] 0 0
France
State/province [87] 0 0
Le Havre
Country [88] 0 0
France
State/province [88] 0 0
Lille
Country [89] 0 0
France
State/province [89] 0 0
Montpellier
Country [90] 0 0
France
State/province [90] 0 0
Paris
Country [91] 0 0
France
State/province [91] 0 0
Pontoise
Country [92] 0 0
France
State/province [92] 0 0
Vannes
Country [93] 0 0
France
State/province [93] 0 0
Venissieux
Country [94] 0 0
France
State/province [94] 0 0
Villeurbanne
Country [95] 0 0
Germany
State/province [95] 0 0
Dortmund
Country [96] 0 0
Germany
State/province [96] 0 0
Dresden
Country [97] 0 0
Germany
State/province [97] 0 0
Elsterwerda
Country [98] 0 0
Germany
State/province [98] 0 0
Essen
Country [99] 0 0
Germany
State/province [99] 0 0
Frankfurt
Country [100] 0 0
Germany
State/province [100] 0 0
Hamburg
Country [101] 0 0
Germany
State/province [101] 0 0
Heidelberg
Country [102] 0 0
Germany
State/province [102] 0 0
Leipzig
Country [103] 0 0
Germany
State/province [103] 0 0
Ludwigsburg
Country [104] 0 0
Germany
State/province [104] 0 0
Münster
Country [105] 0 0
Germany
State/province [105] 0 0
Oldenburg in Holstein
Country [106] 0 0
Germany
State/province [106] 0 0
Saint Ingbert-Oberwürzbach
Country [107] 0 0
Germany
State/province [107] 0 0
Witten
Country [108] 0 0
India
State/province [108] 0 0
Andhra Pradesh
Country [109] 0 0
India
State/province [109] 0 0
Assam
Country [110] 0 0
India
State/province [110] 0 0
Gujarat
Country [111] 0 0
India
State/province [111] 0 0
Karnataka
Country [112] 0 0
India
State/province [112] 0 0
Kerala
Country [113] 0 0
India
State/province [113] 0 0
Madhya Pradesh
Country [114] 0 0
India
State/province [114] 0 0
Maharashtra
Country [115] 0 0
India
State/province [115] 0 0
New Delhi
Country [116] 0 0
India
State/province [116] 0 0
Orissa
Country [117] 0 0
India
State/province [117] 0 0
Punjab
Country [118] 0 0
India
State/province [118] 0 0
Rajasthan
Country [119] 0 0
India
State/province [119] 0 0
Tamil Nadu
Country [120] 0 0
India
State/province [120] 0 0
Telangana
Country [121] 0 0
India
State/province [121] 0 0
Uttar Pradesh
Country [122] 0 0
India
State/province [122] 0 0
Uttarakhand
Country [123] 0 0
India
State/province [123] 0 0
West Bengal
Country [124] 0 0
India
State/province [124] 0 0
Aligarh
Country [125] 0 0
India
State/province [125] 0 0
Bangalore
Country [126] 0 0
India
State/province [126] 0 0
Jodhpur
Country [127] 0 0
India
State/province [127] 0 0
Nagpur
Country [128] 0 0
India
State/province [128] 0 0
Nashik
Country [129] 0 0
India
State/province [129] 0 0
Pune
Country [130] 0 0
India
State/province [130] 0 0
Surat
Country [131] 0 0
Ireland
State/province [131] 0 0
Connaght
Country [132] 0 0
Ireland
State/province [132] 0 0
Leinster
Country [133] 0 0
Italy
State/province [133] 0 0
BA
Country [134] 0 0
Italy
State/province [134] 0 0
LT
Country [135] 0 0
Italy
State/province [135] 0 0
MI
Country [136] 0 0
Italy
State/province [136] 0 0
Pv
Country [137] 0 0
Italy
State/province [137] 0 0
RM
Country [138] 0 0
Italy
State/province [138] 0 0
Si
Country [139] 0 0
Italy
State/province [139] 0 0
VE
Country [140] 0 0
Italy
State/province [140] 0 0
Acquaviva delle Fonti
Country [141] 0 0
Italy
State/province [141] 0 0
Ancona
Country [142] 0 0
Italy
State/province [142] 0 0
Bologna
Country [143] 0 0
Italy
State/province [143] 0 0
Catania
Country [144] 0 0
Italy
State/province [144] 0 0
Chieti Scalo
Country [145] 0 0
Italy
State/province [145] 0 0
Firenze
Country [146] 0 0
Italy
State/province [146] 0 0
Milano
Country [147] 0 0
Italy
State/province [147] 0 0
Modena
Country [148] 0 0
Italy
State/province [148] 0 0
Napoli
Country [149] 0 0
Italy
State/province [149] 0 0
Palermo
Country [150] 0 0
Italy
State/province [150] 0 0
Parma
Country [151] 0 0
Italy
State/province [151] 0 0
Pisa
Country [152] 0 0
Italy
State/province [152] 0 0
Roma
Country [153] 0 0
Italy
State/province [153] 0 0
Sesto San Giovanni (MI)
Country [154] 0 0
Japan
State/province [154] 0 0
Fukushima, Japan
Country [155] 0 0
Japan
State/province [155] 0 0
Kumamoto, Japan
Country [156] 0 0
Japan
State/province [156] 0 0
Chiba-shi, Chiba
Country [157] 0 0
Japan
State/province [157] 0 0
Ehime
Country [158] 0 0
Japan
State/province [158] 0 0
Ibaraki
Country [159] 0 0
Japan
State/province [159] 0 0
Minato-ku, Tokyo
Country [160] 0 0
Japan
State/province [160] 0 0
Mito-shi, Ibaraki
Country [161] 0 0
Japan
State/province [161] 0 0
Okinawa
Country [162] 0 0
Japan
State/province [162] 0 0
Osaka-city, Osaka
Country [163] 0 0
Japan
State/province [163] 0 0
Osaka
Country [164] 0 0
Japan
State/province [164] 0 0
Saga
Country [165] 0 0
Japan
State/province [165] 0 0
Takamatsu-shi, Kagawa
Country [166] 0 0
Japan
State/province [166] 0 0
Takasaki-shi, Gunma
Country [167] 0 0
Japan
State/province [167] 0 0
Tokyo
Country [168] 0 0
Japan
State/province [168] 0 0
Wakayama
Country [169] 0 0
Japan
State/province [169] 0 0
Wako-shi, Saitama
Country [170] 0 0
Malaysia
State/province [170] 0 0
Penang
Country [171] 0 0
Malaysia
State/province [171] 0 0
Perak
Country [172] 0 0
Malaysia
State/province [172] 0 0
Sarawak
Country [173] 0 0
Malaysia
State/province [173] 0 0
Selangor
Country [174] 0 0
Malaysia
State/province [174] 0 0
Wilayah Persekutuan Kuala Lumpur
Country [175] 0 0
Malaysia
State/province [175] 0 0
Kuching
Country [176] 0 0
Malaysia
State/province [176] 0 0
Melaka
Country [177] 0 0
Malaysia
State/province [177] 0 0
Shah Alam
Country [178] 0 0
Malaysia
State/province [178] 0 0
Temerloh,Pahang
Country [179] 0 0
Mexico
State/province [179] 0 0
Jalisco
Country [180] 0 0
Mexico
State/province [180] 0 0
Morelos
Country [181] 0 0
Mexico
State/province [181] 0 0
Nuevo León
Country [182] 0 0
Mexico
State/province [182] 0 0
San Luis Potosi
Country [183] 0 0
Mexico
State/province [183] 0 0
Tamaulipas
Country [184] 0 0
Mexico
State/province [184] 0 0
Veracruz
Country [185] 0 0
Mexico
State/province [185] 0 0
Aguascalientes
Country [186] 0 0
Netherlands
State/province [186] 0 0
Apeldoorn
Country [187] 0 0
Netherlands
State/province [187] 0 0
Eindhoven
Country [188] 0 0
Netherlands
State/province [188] 0 0
Gouda
Country [189] 0 0
Netherlands
State/province [189] 0 0
Groningen
Country [190] 0 0
Netherlands
State/province [190] 0 0
Leeuwarden
Country [191] 0 0
Netherlands
State/province [191] 0 0
Nijmegen
Country [192] 0 0
Netherlands
State/province [192] 0 0
Rotterdam
Country [193] 0 0
Netherlands
State/province [193] 0 0
Sneek
Country [194] 0 0
Netherlands
State/province [194] 0 0
Tiel
Country [195] 0 0
Poland
State/province [195] 0 0
Kuyavian-Pomeranian Voivodeship
Country [196] 0 0
Poland
State/province [196] 0 0
Lodzkie
Country [197] 0 0
Poland
State/province [197] 0 0
Lower Silesian Province
Country [198] 0 0
Poland
State/province [198] 0 0
Lublin Province
Country [199] 0 0
Poland
State/province [199] 0 0
Lubuskie
Country [200] 0 0
Poland
State/province [200] 0 0
Malopolskie
Country [201] 0 0
Poland
State/province [201] 0 0
Masovian Province
Country [202] 0 0
Poland
State/province [202] 0 0
Masovian
Country [203] 0 0
Poland
State/province [203] 0 0
Mazowieckie
Country [204] 0 0
Poland
State/province [204] 0 0
Podlaskie
Country [205] 0 0
Poland
State/province [205] 0 0
Pomorskie
Country [206] 0 0
Poland
State/province [206] 0 0
Silesia
Country [207] 0 0
Poland
State/province [207] 0 0
Slaskie
Country [208] 0 0
Poland
State/province [208] 0 0
Wielkopolskie Voivodeship
Country [209] 0 0
Poland
State/province [209] 0 0
Wielkopolskie
Country [210] 0 0
Poland
State/province [210] 0 0
Bialystok
Country [211] 0 0
Poland
State/province [211] 0 0
Bielsko-Biala
Country [212] 0 0
Poland
State/province [212] 0 0
Bygdoszcz
Country [213] 0 0
Poland
State/province [213] 0 0
Chojnice
Country [214] 0 0
Poland
State/province [214] 0 0
Dabrowka
Country [215] 0 0
Poland
State/province [215] 0 0
Gorzow Wielkopolski
Country [216] 0 0
Poland
State/province [216] 0 0
Katowice
Country [217] 0 0
Poland
State/province [217] 0 0
Krakow
Country [218] 0 0
Poland
State/province [218] 0 0
Lodz
Country [219] 0 0
Poland
State/province [219] 0 0
Lublin
Country [220] 0 0
Poland
State/province [220] 0 0
Piotrkow Trybunalski
Country [221] 0 0
Poland
State/province [221] 0 0
Staszow
Country [222] 0 0
Poland
State/province [222] 0 0
Tychy
Country [223] 0 0
Poland
State/province [223] 0 0
Warszawa
Country [224] 0 0
Poland
State/province [224] 0 0
Wroclaw
Country [225] 0 0
Poland
State/province [225] 0 0
Zabrze
Country [226] 0 0
Poland
State/province [226] 0 0
Zamosc
Country [227] 0 0
Serbia
State/province [227] 0 0
RS
Country [228] 0 0
Serbia
State/province [228] 0 0
Vojvodina
Country [229] 0 0
Serbia
State/province [229] 0 0
Belgrade
Country [230] 0 0
Serbia
State/province [230] 0 0
Kragujevac
Country [231] 0 0
Serbia
State/province [231] 0 0
Zajecar
Country [232] 0 0
South Africa
State/province [232] 0 0
Eastern Cape
Country [233] 0 0
South Africa
State/province [233] 0 0
Gauteng
Country [234] 0 0
South Africa
State/province [234] 0 0
KwaZulu-Natal
Country [235] 0 0
South Africa
State/province [235] 0 0
Western Cape
Country [236] 0 0
Spain
State/province [236] 0 0
Madrid
Country [237] 0 0
Spain
State/province [237] 0 0
Antequera
Country [238] 0 0
Spain
State/province [238] 0 0
Barcelona
Country [239] 0 0
Spain
State/province [239] 0 0
Castilleja Dela Cuesta Sevilla
Country [240] 0 0
Spain
State/province [240] 0 0
Córdoba
Country [241] 0 0
Spain
State/province [241] 0 0
Las Palmas de Gran Canaria
Country [242] 0 0
Spain
State/province [242] 0 0
Málaga
Country [243] 0 0
Spain
State/province [243] 0 0
Palma de Mallorca
Country [244] 0 0
Spain
State/province [244] 0 0
Pozuelo de Alarcón
Country [245] 0 0
Spain
State/province [245] 0 0
Sanlúcar de Barrameda
Country [246] 0 0
Spain
State/province [246] 0 0
Sevilla
Country [247] 0 0
Spain
State/province [247] 0 0
Toledo
Country [248] 0 0
Spain
State/province [248] 0 0
Valencia
Country [249] 0 0
Thailand
State/province [249] 0 0
Bangkok
Country [250] 0 0
Thailand
State/province [250] 0 0
Nakhon Ratchasima
Country [251] 0 0
Thailand
State/province [251] 0 0
Pathumthani
Country [252] 0 0
Thailand
State/province [252] 0 0
Chiang Mai
Country [253] 0 0
Thailand
State/province [253] 0 0
Khon Kaen
Country [254] 0 0
Thailand
State/province [254] 0 0
Muang
Country [255] 0 0
Thailand
State/province [255] 0 0
Songkla
Country [256] 0 0
Turkey
State/province [256] 0 0
Bahcelievler
Country [257] 0 0
Turkey
State/province [257] 0 0
Kartal
Country [258] 0 0
Turkey
State/province [258] 0 0
Odunpazari
Country [259] 0 0
Turkey
State/province [259] 0 0
Yildirim
Country [260] 0 0
Turkey
State/province [260] 0 0
Adana
Country [261] 0 0
Turkey
State/province [261] 0 0
Afyon
Country [262] 0 0
Turkey
State/province [262] 0 0
Ankara
Country [263] 0 0
Turkey
State/province [263] 0 0
Edirne
Country [264] 0 0
Turkey
State/province [264] 0 0
Eskisehir
Country [265] 0 0
Turkey
State/province [265] 0 0
Istanbul
Country [266] 0 0
Turkey
State/province [266] 0 0
Izmir
Country [267] 0 0
Turkey
State/province [267] 0 0
Kahramanmaras
Country [268] 0 0
Turkey
State/province [268] 0 0
Kayseri
Country [269] 0 0
Turkey
State/province [269] 0 0
Kocaeli
Country [270] 0 0
Turkey
State/province [270] 0 0
Kutahya
Country [271] 0 0
Turkey
State/province [271] 0 0
Mersin
Country [272] 0 0
Turkey
State/province [272] 0 0
Samsun
Country [273] 0 0
United Kingdom
State/province [273] 0 0
Lancashire
Country [274] 0 0
United Kingdom
State/province [274] 0 0
Bradford-on-Avon
Country [275] 0 0
United Kingdom
State/province [275] 0 0
Bradford
Country [276] 0 0
United Kingdom
State/province [276] 0 0
Bristol
Country [277] 0 0
United Kingdom
State/province [277] 0 0
Chester
Country [278] 0 0
United Kingdom
State/province [278] 0 0
Coventry
Country [279] 0 0
United Kingdom
State/province [279] 0 0
Dundee
Country [280] 0 0
United Kingdom
State/province [280] 0 0
Edinburgh
Country [281] 0 0
United Kingdom
State/province [281] 0 0
Exeter
Country [282] 0 0
United Kingdom
State/province [282] 0 0
Glasgow
Country [283] 0 0
United Kingdom
State/province [283] 0 0
Hull
Country [284] 0 0
United Kingdom
State/province [284] 0 0
Ipswich
Country [285] 0 0
United Kingdom
State/province [285] 0 0
Leeds
Country [286] 0 0
United Kingdom
State/province [286] 0 0
Leicester
Country [287] 0 0
United Kingdom
State/province [287] 0 0
London
Country [288] 0 0
United Kingdom
State/province [288] 0 0
Newcastle upon Tyne
Country [289] 0 0
United Kingdom
State/province [289] 0 0
Plymouth
Country [290] 0 0
United Kingdom
State/province [290] 0 0
Redhill
Country [291] 0 0
United Kingdom
State/province [291] 0 0
Rotherham
Country [292] 0 0
United Kingdom
State/province [292] 0 0
Soham
Country [293] 0 0
United Kingdom
State/province [293] 0 0
Truro
Country [294] 0 0
United Kingdom
State/province [294] 0 0
West Sussex

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Novo Nordisk A/S
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
This study will look at the effects of CagriSema on cardiovascular events (for example heart
attack and stroke) in people living with cardiovascular disease. Participants will either get
CagriSema or a dummy medicine (also called "placebo") which has no effect on the body. Which
treatment participants will get will be decided by chance. Participant's chance of getting
CagriSema or placebo is the same. Participants will inject the study medicine once a week.
The study medicine will be injected briefly with a thin needle, typically in the stomach,
thighs or upper arms. The study will last for up to 4.5 years.
Trial website
https://clinicaltrials.gov/ct2/show/NCT05669755
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Clinical Transparency dept. 2834
Address 0 0
Novo Nordisk A/S
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Novo Nordisk
Address 0 0
Country 0 0
Phone 0 0
(+1) 866-867-7178
Fax 0 0
Email 0 0
clinicaltrials@novonordisk.com
Contact person for scientific queries



What supporting documents are/will be available?

No Supporting Document Provided

Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.
For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT05669755